This early-stage study is testing the safety of an experimental treatment called NCS-01 for people who recently had a stroke. Sixteen participants will receive the treatment directly into an artery in their neck within 48 hours of their stroke. Researchers will monitor for side e…
Phase: PHASE1, PHASE2 • Sponsor: NC Medial Research Inc • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC